Stay updated on ITI-007 in Schizophrenia: Efficacy Study Clinical Trial
Sign up to get notified when there's something new on the ITI-007 in Schizophrenia: Efficacy Study Clinical Trial page.
Latest updates to the ITI-007 in Schizophrenia: Efficacy Study Clinical Trial page
- Check6 days agoChange DetectedAdded a new Locations section highlighting New York as the study site. Removed ancillary items including HHS Vulnerability Disclosure, MedlinePlus Genetics, and New York Locations.SummaryDifference0.4%
- Check14 days agoChange DetectedAdded related topics: Schizophrenia and MedlinePlus Genetics to the related topics section.SummaryDifference0.2%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRelated topics list items Schizophrenia, related topics, and MedlinePlus Genetics were removed from the page. This change affects metadata but not the main study details.SummaryDifference0.2%
- Check35 days agoChange DetectedAdded Schizophrenia as the condition and related topics including MedlinePlus Genetics. The site revision was updated to v3.3.2, replacing v3.2.0.SummaryDifference0.3%
- Check42 days agoChange DetectedDeleted the government funding lapse notice and the related topics section (Schizophrenia; MedlinePlus Genetics). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%
- Check57 days agoChange DetectedStudy record layout and navigation appear updated, while core information such as the title, condition (schizophrenia), intervention (ITI-007), eligibility, and primary outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
Stay in the know with updates to ITI-007 in Schizophrenia: Efficacy Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ITI-007 in Schizophrenia: Efficacy Study Clinical Trial page.